Kynurenine disposition in blood and brain of mice: Effects of selective inhibitors of kynurenine hydroxylase and of kynureninase

Journal of Neurochemistry

Volumn 67, Issue 2, 1996, Pages 692-698

  Chiarugi, Alberto ^a   Carpenedo, Raffaella ^a   Moroni, Flavio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Kynurenic acid; Kynureninase; Kynurenine; Kynurenine hydroxylase; NMDA; Quinolinic acid

Indexed keywords

ANTHRANILIC ACID; KYNURENINASE; KYNURENINE; KYNURENINE 3 MONOOXYGENASE; N METHYL DEXTRO ASPARTIC ACID; QUINOLINIC ACID;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HYDROLYSIS; HYDROXYLATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030035748     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67020692.x     Document Type: Article

References (35)

1. Bender D. A. and McCreanor G. M. (1982) The preferred route of kynurenine metabolism in the rat. Biochim. Biophys. Acta 717, 56-60.
2. Carpenedo R., Chiarugi A., Russi P., Lombardi G., Carlà V., Pellicciari R., Mattoli L., and Moroni F. (1994) Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenic acid and have sedative and anticonvulsant activities. Neuroscience 61, 237-244.
3. Chiarugi A., Carpenedo R., Molina M. T., Mattoli L., Pellicciari R., and Moroni F. (1995) Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase. J. Neurochem. 65, 1176-1183.
4. Eastman C. L. and Guilarte T. R. (1989) Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line. Brain Res. 495, 225-231.
5. Flanagan E. M., Erickson J. B., Viveros O. H., Chang S. Y., and Reinhard J. F. Jr. (1995) Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis. J. Neurochem. 64, 1192-1196.
6. Foster A. C., White R. J., and Schwarcz R. (1986) Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro. J. Neurochem. 47, 23-30.
7. Fukui S., Schwarcz R., Rapoport S. I., Takada Y., and Smith Q. R. (1995) Blood-barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 2007-2017.
8. Gal E. M. and Sherman A. D. (1978) Synthesis and metabolism of L-kynurenine in rat brain. J. Neurochem. 30, 607-613.
9. Haber R., Bessette D., Hulihan-Giblin B., Durcan M. J., and Goldman D. (1993) Identification of tryptophan 2,3-dioxygenase RNA in rodent brain. J. Neurochem. 60, 1159-1162.
10. Heyes M. P. and Quearry B. J. (1988) Quantification of 3-hydroxykynurenine in the brain by HPLC and electrochemical detection. J. Chromatogr. 428, 340-344.
11. Heyes M. P., Brew B. J., Martin A., Price R. W., Salazar A. M., Sidtis J. J., Yergey J. A., Mouradian M. M., Sadler A. E., Keilp J., Rubinov D., and Markey S. P. (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29, 202-209.
12. Holmes E. W. (1988) Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by HPLC. Anal. Biochem. 172, 518-525.
13. Johnson J. W. and Ascher P. (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325, 529-531.
14. Kessler M., Terramani T., Lynch G., and Baudry M. (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterisation and identification of a new class of antagonists. J. Neurochem. 52, 1319-1328.
15. Lapin I. P. (1980) Experimental studies on kynurenine as neuroactive tryptophan metabolites: past, present and future. Trends Pharmacol. Sci. 1, 410-413.
16. McDermott C. E., Casciano D. A., and Gaertner F. H. (1973) Isolation and characterization of an hydroxykynureninase from homogenates of adult mouse liver. Biochem. Biophys. Res. Commun. 51, 813-818.
17. Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11, 379-387.
18. Molina M. T. and Escribano A. M. (1991) Alkylation of Schiff bases with phenacyl bromides: synthesis of gamma-keto-alpha-amino acids. Seventh Meeting of the Spanish Society for Therapeutic Chemistry. P-43.
19. Moroni F., Russi P., Lombardi G., Beni M., and Carlà V. (1988) Presence of kynurenic acid in the mammalian brain. J. Neurochem. 51, 177-181.
20. Moroni F., Russi P., Gallo-Mezo M. A., Moneti G., and Pellicciari R. (1991) Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. J. Neurochem. 57, 1630-1635.
21. Pellegrini-Giampietro D. E., Galli A., Alesiani M., Cherici G., and Moroni F. (1989) Quinoxalines interact with the glycine recognition site of NMDA receptors: studies in guinea-pig myenteric plexus and in rat cortical membranes. Br. J. Pharmacol. 98, 1281-1286.
22. Pellicciari R., Natalini B., Costantino G., Mahmoud M. R., Mattoli L., Sadeghpour B. M., Moroni F., Chiarugi A., and Carpenedo R. (1994) Modulation of the kynurenine pathway in search for new neuroprotective agents: synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase. J. Med. Chem. 37, 647-655.
23. Perkins M. N. and Stone T. W. (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interactions with the endogenous excitant quinolinic acid. Brain Res. 247, 184-187.
24. Reinhard J. F. Jr., Erickson J. B., and Flanagan E. M. (1994) Quinolinic acid in neurological disease: opportunity for novel drug discovery. Adv. Pharmacol. 40, 85-127.
25. Rogawski M. (1992) The NMDA receptor, NMDA antagonists and epilepsy therapy. Drugs 44, 279-292.
26. Russi P., Alesiani M., Lombardi G., Davolio P., Pellicciari R., and Moroni F. (1992) Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions. J. Neurochem. 59, 2076-2080.
27. Schwarcz R., Whetsell W. O., and Mangano R. M. (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316-318.
28. Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45, 309-379.
29. Stone T. W. and Perkins M. N. (1981) Quinolinic acid: a potent, endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol. 72, 411-412.
30. Swartz K. J., During M. J., Freese A., and Beal M. F. (1990) Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J. Neurosci. 10, 2965-2973.
31. Takeuchi F., Otsuka H., and Shibata Y. (1980) Purification and properties of kynureninase from rat liver. J. Biochem. (Tokyo) 88, 987-994.
32. Ueda T., Otsuka H., Goda K., Ishiguro I., Naito J., and Kotake Y. (1978) The metabolism of 14C-anthranilic acid 1: the incorporation of radioactivity to NAD and NADP. J. Biochem. (Tokyo) 84, 687-696.
33. Varesio L., Clayton E., Blasi R., Ruffman R., and Radzioch D. (1990) Picolinic acid, a catabolite of tryptophan, as the second signal in the activation of interferon gamma-primed macrophages. J. Immunol. 145, 4265-4269.
34. Wu H., Ungerstedt U., and Schwarcz R. (1992) Regulation of kynurenic acid synthesis studied by microdialysis in the dorsal hippocampus of unanesthetized rats. Eur. J. Pharmacol. 213, 375-380.
35. Yoshida R. and Hayashi O. (1987) Indoleamine 2,3-dioxygenase. Methods Enzymol. 142, 188-195.